Despite advancements in reperfusion therapies—such as intravenous thrombolysis (IVT) with tissue plasminogen activator (tPA) and endovascular thrombectomy (EVT)—many stroke survivors experience persistent disability or death, underscoring the importance of identifying modifiable prognostic factors (2). Here, PLAT is linked to Stroke.